Shaw Timothy reported tax withholding involving 3,459 shares of MARIMED INC. at $0.07 for −$241 on Oct 2, 2026

Tax withholding
Form 4 code F. Payment of an exercise price or tax liability by delivering or withholding securities in a Rule 16b-3 transaction.
Chief Operating Officer
Chief Operating Officer
Filed Oct 2, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$240.75Shares × reported price
Shares traded
3,459Common stock
Price per share
$0.07Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
9,461,122Direct
Trade date
Oct 2, 2026Tax withholding
Filed
Oct 2, 2026, 4:06 PM ET0-day reporting delay
Accession
0001522767-26-000197Code F · Transaction 234306
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Oct 2, 2026Option exercise9,981$0.00$0Trade 234305
Oct 2, 2026Option exercise9,981$0.00$0Trade 234307
3 transaction rows in this filing. Joint filers share the same rows.

MRMD price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MRMD · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Oct 9, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Footnotes in full

F1: RSUs convert to shares of common stock on a one-for-one basis. F2: Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs. F3: The Reporting Person's spouse is the trustee of the trust and the shares held in the trust are for the benefit of the Reporting Person's children. The trust is an irrevocable trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. F4: The RSUs were granted on April 2, 2024; the remaining RSUs under this grant will vest in full on April 2, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.